Natco Pharma
₹789
- Market Cap
- ₹15,419Cr.
- P/E Ratio
- 13.5
- P/B Ratio
- 1.68
- EPS (TTM)
- ₹58.44
- Div Yield
- 0.63%
- ROCE
- 17.4%
- ROE
- 17.1%
52W Low: ₹77952W High: ₹1,227
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 15.0% a year over three years.
- Debt is 0.08× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Natco_Pharma — Price
Interval
Style
Failed: 503
Evenstocks Score
Upper third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 13.5P/E: 13.5 | P/B: 1.68Growth
GrowingSales CAGR — 3Y: 15% · 1Y: -21%Profitability
ModerateROCE: 17.4% | ROE: 17.1%Key Metrics
Valuation
PEG Ratio 0.50
Price / Sales 4.42x
Price / FCF 11.2x
Book Value ₹470
Margins & returns
Operating Margin 30%